Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed at $36.40 in the last session, down -3.58% from day before closing price of $37.75. In other words, the price has decreased by -$3.58 from its previous closing price. On the day, 0.79 million shares were traded. SUPN stock price reached its highest trading level at $37.75 during the session, while it also had its lowest trading level at $36.23.
Ratios:
We take a closer look at SUPN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.20. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on September 11, 2024, Downgraded its rating to Neutral and sets its target price to $36 from $41 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 07 ’24 when JACK A KHATTAR bought 125,000 shares for $36.68 per share.
FRANK MOTTOLA bought 15,000 shares of SUPN for $554,692 on Nov 07 ’24. On Nov 07 ’24, another insider, GEORGES GEMAYEL, who serves as the Director of the company, bought 14,213 shares for $36.62 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 2084526208 and an Enterprise Value of 1644924544. As of this moment, Supernus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.08, and their Forward P/E ratio for the next fiscal year is 19.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 20.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.08 while its Price-to-Book (P/B) ratio in mrq is 2.00. Its current Enterprise Value per Revenue stands at 2.523 whereas that against EBITDA is 11.421.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $39.37, while it has fallen to a 52-week low of $23.05. The 50-Day Moving Average of the stock is 9.96%, while the 200-Day Moving Average is calculated to be 18.65%.
Shares Statistics:
According to the various share statistics, SUPN traded on average about 395.91K shares per day over the past 3-months and 462360 shares per day over the past 10 days. A total of 54.72M shares are outstanding, with a floating share count of 52.76M. Insiders hold about 4.25% of the company’s shares, while institutions hold 108.38% stake in the company. Shares short for SUPN as of 1728950400 were 6769850 with a Short Ratio of 17.10, compared to 1726185600 on 6798029. Therefore, it implies a Short% of Shares Outstanding of 6769850 and a Short% of Float of 18.65.
